S. Hüning

Medical treatment of advanced cutaneous squamous‐cell carcinoma

R. Gutzmer, S. Beissert, E. Stockfleth, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial

J. Utikal, C. Berking, K. Kähler, 2020, Journal of clinical medicine.

Squamous cell carcinoma of the lower extremities induced by cesium‐137 exposition

D. Nashan, A. Block, S. Hüning, 2021, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients

C. Berking, D. Schadendorf, B. Schilling, 2021, Cancers.

Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial).

K. Kähler, A. Bohne, L. Heinzerling, 2023, Journal of cancer research and clinical oncology.

Immune checkpoint inhibition and targeted therapy for melanoma: A patient‐oriented cross‐sectional comparative multicentre study

S. Haferkamp, M. Gaiser, R. Gutzmer, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world Dermatologic Cooperative Oncology Group study

A. Hauschild, D. Schadendorf, K. Kähler, 2023, European Journal of Cancer.

Chlormethin-Gel-basierte komplette Remission einer CD30-positiven Mycosis fungoides-Plaque

D. Nashan, S. Hüning, A. Lücke, 2021, Aktuelle Dermatologie.

Short- and long-term immunosuppressive effects of melanoma influence the prognostic value of the sentinel lymph node status.

D. Schrama, Nalini Srinivas, Cathrin Ritter, 2024, European journal of cancer.